YARROW BIOSCIENCE, INC. License and Services Revenue (Deprecated 2018-01-31)
YARROW BIOSCIENCE, INC. (YARW) reported License and Services Revenue (Deprecated 2018-01-31) of $497.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2018-05-09
- YARROW BIOSCIENCE, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $497.00K, a 10.69% increase year-over-year.
- YARROW BIOSCIENCE, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.77M, a 516.67% increase year-over-year.
- YARROW BIOSCIENCE, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $909.00K, a 305.80% increase year-over-year.
- YARROW BIOSCIENCE, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $449.00K.
- YARROW BIOSCIENCE, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2017 was $4.58M, a 579.82% increase from fiscal 2016.
- YARROW BIOSCIENCE, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2016 was $674.00K.
- YARROW BIOSCIENCE, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2015 was $0.00.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month | License and Services Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $497.00K 10-Q · filed 2018-05-09 | $3.27M derived: sum of 2 quarters · filed 2018-05-09 | $4.18M derived: sum of 3 quarters · filed 2018-05-09 | $4.63M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | $2.77M 10-K · filed 2018-03-28 | $3.68M derived: sum of 2 quarters · filed 2018-03-28 | $4.13M derived: sum of 3 quarters · filed 2018-03-28 | $4.58M 10-K · filed 2018-03-28 |
| 2017-09-30 | $909.00K 10-K · filed 2018-03-28 | $1.36M derived: sum of 2 quarters · filed 2018-03-28 | $1.81M derived: sum of 3 quarters · filed 2018-05-09 | $2.26M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | $449.00K 10-K · filed 2018-03-28 | $898.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.35M derived: sum of 3 quarters · filed 2018-05-09 | $1.57M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | $449.00K 10-Q · filed 2018-05-09 | $899.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.12M derived: sum of 3 quarters · filed 2018-05-09 | $1.12M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $450.00K 10-K · filed 2018-03-28 | $674.00K derived: sum of 2 quarters · filed 2018-03-28 | $674.00K derived: sum of 3 quarters · filed 2018-03-28 | $674.00K 10-K · filed 2018-03-28 |
| 2016-09-30 | $224.00K 10-K · filed 2018-03-28 | $224.00K derived: sum of 2 quarters · filed 2018-03-28 | $224.00K derived: sum of 3 quarters · filed 2018-03-28 | |
| 2016-06-30 | $0.00 10-K · filed 2018-03-28 | $0.00 derived: sum of 2 quarters · filed 2018-03-28 | ||
| 2016-03-31 | $0.00 10-K · filed 2018-03-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |